Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2020
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women
Emma Hughes, Norah Mwebaza, Liusheng Huang, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2023
Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention
Howard Hong, Usman Aslam-Mir, Richard Kajubi, et al.
Malaria Journal
|
September 26, 2015
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children
Kerstin Sundell, Prasanna Jagannathan, Liusheng Huang, et al.
Scientific Reports
|
June 13, 2018
Elevated plasma abscisic acid is associated with asymptomatic falciparum malaria and with IgG-/caspase-1-dependent immunity in Plasmodium yoelii-infected mice
Elizabeth K K Glennon, Dewi Megawati, Brandi K Torrevillas, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 3, 2024
Determination of sulfadoxine and pyrimethamine in microvolume human plasma using ultra high performance liquid chromatography-tandam mass spectrometry
Vong Sok, Florence Marzan, Michelle Roh, et al.
Nature Communications
|
May 7, 2024
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children
Justin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 12, 2020
Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV
David Gingrich, Amelia N Deitchman, Amy Kantor, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria
Myaing M Nyunt, Vy K Nguyen, Richard Kajubi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 5, 2016
Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
Sunil Parikh, Richard Kajubi, Liusheng Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2022
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial
Meghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2020
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women
Emma Hughes, Norah Mwebaza, Liusheng Huang, et al.
Antimicrobial Agents and Chemotherapy
|
March 14, 2023
Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention
Howard Hong, Usman Aslam-Mir, Richard Kajubi, et al.
Malaria Journal
|
September 26, 2015
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children
Kerstin Sundell, Prasanna Jagannathan, Liusheng Huang, et al.
Scientific Reports
|
June 13, 2018
Elevated plasma abscisic acid is associated with asymptomatic falciparum malaria and with IgG-/caspase-1-dependent immunity in Plasmodium yoelii-infected mice
Elizabeth K K Glennon, Dewi Megawati, Brandi K Torrevillas, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
February 3, 2024
Determination of sulfadoxine and pyrimethamine in microvolume human plasma using ultra high performance liquid chromatography-tandam mass spectrometry
Vong Sok, Florence Marzan, Michelle Roh, et al.
Nature Communications
|
May 7, 2024
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children
Justin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 12, 2020
Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV
David Gingrich, Amelia N Deitchman, Amy Kantor, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria
Myaing M Nyunt, Vy K Nguyen, Richard Kajubi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 5, 2016
Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
Sunil Parikh, Richard Kajubi, Liusheng Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2022
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial
Meghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Page
of 8